Liver / Pancreas

NAFLD increases mortality in diabetes patients

17/02/2010 | Doctors are being urged to evaluate patients with type 2 diabetes for non-alcoholic fatty liver disease after a study found it increases the overall risk of death.


Gastric ulcers increase pancreatic cancer risk

03/02/2010 | Patients with gastric ulcers are at increased risk of pancreatic cancer, but the association is not the same for duodenal ulcers, a large prospective study finds.


Doctors call for ban on liver toxic herbal supplement

03/02/2010 | The first Australian case of acute liver toxicity caused by an over-the-counter herbal weight loss supplement has been reported by two Sydney-based physicians.


New test predicts chronic hepatitis B

20/01/2010 | New research has found a non-invasive test that determines the presence and severity of liver disease may be better than existing methods to predict liver cirrhosis in patients with chronic hepatitis B.


Important news for newsletter subscribers

11/11/2009 | We have recently updated our newsletter distribution technology and are sending the newsletter from a new email address.


Obesity important in NAFLD

23/10/2009 | The important role obesity plays in NAFLD needs to be acknowledged, according to a panel discussion at the AGW annual conference.


Majority of Hep B patients resistant to antiviral therapy

22/10/2009 | The majority of hepatitis B patients have a genotypic resistance to antiviral therapy, results of the CHARM study show.


Laparoscopic liver resection feasible

14/10/2009 | Laparoscopic major liver resections are feasible as long as the patient is carefully selected and the surgeon is experienced, a study of international outcomes finds.


Gene predicts HCV treatment success

14/09/2009 | Australian scientists have added to research linking the IL28B genotype with response to pegylated interferon-alfa/ribavirin treatment in patients with chronic hepatitis C.


Sexual impairment common among men treated for Hep C

12/09/2009 | Sexual impairment is common among men with chronic hepatitis C undergoing therapy with pegylated interferon and ribavirin and should be considered as a potential side effect of antiviral therapy, a study finds.


More Liver / Pancreas news

Most viewed articles this week

Recent comments

Related sites